Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CytoGenix Announces New Analyst Report with Speculative Buy Rating.


HOUSTON Houston, city (1990 pop. 1,630,553), seat of Harris co., SE Tex., a deepwater port on the Houston Ship Channel; inc. 1837. Economy


The fourth largest city in the nation and the largest in the entire South and Southwest, Houston is a port of entry;
 -- CytoGenix, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CYGX) announced that it is being covered by JM Dutton & Associates. The report can be found by visiting JM Dutton at www.jmdutton.com. Dr. William R. Prather, JM Dutton's senior healthcare market analyst, authored this independent analysis of the Company.

Dr. Prather concludes, "At current levels, the Company remains an unexploited, virtually undiscovered company with exciting new technology. Our rating for CytoGenix shares is a Speculative Buy with a 12-month price target of $0.90."

Lawrence Wunderlich, CytoGenix Chief Financial Officer, commented, "We are encouraged by Dr. Prather's findings. Although in our opinion, they are somewhat conservative. We both agree that the Company is significantly undervalued Undervalued

A stock or other security that is trading below its true value.

Notes:
The difficulty is knowing what the "true" value actually is. Analysts will usually recommend an undervalued stock with a strong buy rating.
 by the market. The true value of a biopharmaceutical company is reflected in its pipeline. Our product pipeline is solid proof that our products address very large markets and that we continue to add value," added Mr. Wunderlich.

CytoGenix, Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of high purity Purity: see Pearl, The.
Purity
See also Modesty.

almond

symbol of the Virgin Mary’s innocence. [O.T.: Numbers 17: 1–11; Art: Hall, 14]

crystal

its transparency symbolizes pureness.
 DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 at fraction of the cost of traditional fermentation fermentation, process by which the living cell is able to obtain energy through the breakdown of glucose and other simple sugar molecules without requiring oxygen. Fermentation is achieved by somewhat different chemical sequences in different species of organisms.  methods. CytoGenix currently has one issued US patent and over 44 international or US pending patent applications claiming methods and materials in connection with this platform technology.

SAFE HARBOR Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 5, 2005
Words:313
Previous Article:Syntel to Announce First Quarter 2005 Results on April 21, 2005.
Next Article:Carpenter Technology Raises Prices on Stainless and Premium-Melted Specialty Alloys.



Related Articles
J.M. Dutton & Associates Announces Investment Opinion: CytoGenix Speculative Buy Rating Issued in Initial Report by Dutton & Associates.
CytoGenix, Inc. Receives Coverage and Rating by Independent Research Firm J.M. Dutton and Associates LLC.
J.M. Dutton & Associates Announces Investment Opinion: CytoGenix Speculative Buy Rating Reiterated In Update Report By Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: CytoGenix Speculative Buy Rating Maintained in Update Report by Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: CytoGenix Rating Maintained at Speculative Buy by Dutton & Associates.
Dutton Associates Announces Investment Opinion on CytoGenix Inc.: Speculative Buy Rating Reiterated in Update by Dutton Associates.
CytoGenix First Quarter 2005 Update.
Dutton Associates Announces Investment Opinion: CytoGenix Rating Maintained at Speculative Buy By Dutton Associates.
Dutton Associates Announces Investment Opinion: CytoGenix Rating Maintained and Price Target Raised By Dutton Associates.
Dutton Associates Announces Investment Opinion: Joystar Rating Maintained at Strong Speculative Buy by Dutton Associates.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles